Year in Review 2024 - Transformative FDA Approvals in Precision Onco…

Oncology 2024 Year in Review

V. Subbiah

Surveillance Imaging in Solid Tumors: More Complicated Than It Appea…

ecancer

C. Booth

DDW 2024 Highlights: Pancreatic Cancer Screening in High Risk Indivi…

DDW 2024 Conference Coverage

T. Kachaamy

ESMO 2024 Summary: Latest Advances in Targeted Therapies for Pancrea…

2024 ESMO Annual Meeting Insights Hub

D. Melisi

Pancreas Cancer: Update and Review

Scripps Health

W. Coyle

ASCO® 2024 Summary: "Advancing GI Cancer Treatment - The Clinical Ut…

2024 ASCO® Annual Meeting Insights Hub

S. Cohen

Targeting KRAS in Pancreatic Cancer

Harshabad Singh

Screening for Pancreatic Cancer

Montefiore Einstein

A. L. Lucas

Pancreatic Adenocarcinoma and Neuroendocrine Tumors - An Update

AdventHealth

M. Tejani

The TAPUR Study: Evaluating Targeted Therapies Based on Genetic Alte…

University of Miami Sylvester Comprehensive Cancer Center

R. Schilsky

ASCO® 2024 Insights: "EXPEL-PANC - A Ph2 Study of BXCL701 + Pembro i…

2024 ASCO® Annual Meeting Insights Hub

B. Weinberg

ESMO GI 2024 Insights: Role of Personalized Medicine in Pancreatic C…

Insights from 2024 ESMO GI Annual Meeting

T. Seufferlein

2024 Updates on Targeted Approaches for GI Cancers and New Data in N…

Total Health

A. Grothey

Precision Medicine in GI Cancers

Fred Hutchinson Cancer Center

D. Zhen

Optimizing 1L Treatment for Metastatic Pancreatic Cancer: Evaluating…

Angelo Pirozzi

Current Management of Locally Advanced Pancreatic Cancer

Integrity CE

A. Narang

Tumor-Agnostic Efficacy & Safety of Selpercatinib in RET Fusion+ Sol…

UCSF School of Medicine

H. Kang

Current Status for the Early Detection of Pancreatic Cancer

Philadelphia County Medical Society

R. Brand

Pancreatic Cancer Updates From Yale Cancer Center

Yale Cancer Center

J. Lacy

DNA Damage Repair Deficiency in Pancreatic Cancer: Case Presentation…

Integrity CE

N. Zaidi, K. Reiss Binder